Selected research
Market Analysis & Forecast
Global Fibrin Sealant (Human) Market Analysis and Forecast 2026-2032
Market perspective
The global Fibrin Sealant (Human) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Fibrin Sealant (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Fibrin Sealant (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Fibrin Sealant (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Fibrin Sealant (Human) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Fibrin Sealant (Human) include Behringwerke, CSL, Grifols, Immuno, Octapharma, Baxter, Bayer, Hualan Biological and Shanghai RAAS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Fibrin Sealant (Human), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Fibrin Sealant (Human), also provides the sales of main regions and countries. Of the upcoming market potential for Fibrin Sealant (Human), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fibrin Sealant (Human) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fibrin Sealant (Human) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fibrin Sealant (Human) sales, projected growth trends, production technology, application and end-user industry.
Fibrin Sealant (Human) Segment by Company
Behringwerke
CSL
Grifols
Immuno
Octapharma
Baxter
Bayer
Hualan Biological
Shanghai RAAS
Fibrin Sealant (Human) Segment by Type
2mL/Set
4mL/Set
10mL/Set
Fibrin Sealant (Human) Segment by Application
Hospital
Clinic
Other
Fibrin Sealant (Human) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Sealant (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Sealant (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Sealant (Human).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Fibrin Sealant (Human) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Fibrin Sealant (Human) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fibrin Sealant (Human) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2mL/Set
- 4mL/Set
- 10mL/Set
Applications
- Hospital
- Clinic
- Other
Companies covered
- Behringwerke
- CSL
- Grifols
- Immuno
- Octapharma
- Baxter
- Bayer
- Hualan Biological
- Shanghai RAAS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Fibrin Sealant (Human) Market by Type
- 1.2.1 Global Fibrin Sealant (Human) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 2mL/Set
- 1.2.3 4mL/Set
- 1.2.4 10mL/Set
- 1.3 Fibrin Sealant (Human) Market by Application
- 1.3.1 Global Fibrin Sealant (Human) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Fibrin Sealant (Human) Market Dynamics
- 2.1 Fibrin Sealant (Human) Industry Trends
- 2.2 Fibrin Sealant (Human) Industry Drivers
- 2.3 Fibrin Sealant (Human) Industry Opportunities and Challenges
- 2.4 Fibrin Sealant (Human) Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Fibrin Sealant (Human) Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Fibrin Sealant (Human) Revenue by Region
- 3.2.1 Global Fibrin Sealant (Human) Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Fibrin Sealant (Human) Revenue by Region (2021-2026)
- 3.2.3 Global Fibrin Sealant (Human) Revenue by Region (2027-2032)
- 3.2.4 Global Fibrin Sealant (Human) Revenue Market Share by Region (2021-2032)
- 3.3 Global Fibrin Sealant (Human) Sales Estimates and Forecasts 2021-2032
- 3.4 Global Fibrin Sealant (Human) Sales by Region
- 3.4.1 Global Fibrin Sealant (Human) Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Fibrin Sealant (Human) Sales by Region (2021-2026)
- 3.4.3 Global Fibrin Sealant (Human) Sales by Region (2027-2032)
- 3.4.4 Global Fibrin Sealant (Human) Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Fibrin Sealant (Human) Revenue by Manufacturers
- 4.1.1 Global Fibrin Sealant (Human) Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Fibrin Sealant (Human) Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Fibrin Sealant (Human) Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Fibrin Sealant (Human) Sales by Manufacturers
- 4.2.1 Global Fibrin Sealant (Human) Sales by Manufacturers (2021-2026)
- 4.2.2 Global Fibrin Sealant (Human) Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Fibrin Sealant (Human) Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Fibrin Sealant (Human) Sales Price by Manufacturers (2021-2026)
- 4.4 Global Fibrin Sealant (Human) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Fibrin Sealant (Human) Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Fibrin Sealant (Human) Manufacturers, Product Type & Application
- 4.7 Global Fibrin Sealant (Human) Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Fibrin Sealant (Human) Market CR5 and HHI
- 4.8.2 2025 Fibrin Sealant (Human) Tier 1, Tier 2, and Tier 3
5 Fibrin Sealant (Human) Market by Type
- 5.1 Global Fibrin Sealant (Human) Revenue by Type
- 5.1.1 Global Fibrin Sealant (Human) Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Fibrin Sealant (Human) Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Fibrin Sealant (Human) Revenue Market Share by Type (2021-2032)
- 5.2 Global Fibrin Sealant (Human) Sales by Type
- 5.2.1 Global Fibrin Sealant (Human) Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Fibrin Sealant (Human) Sales by Type (2021-2032) & (K Tons)
- 5.2.3 Global Fibrin Sealant (Human) Sales Market Share by Type (2021-2032)
- 5.3 Global Fibrin Sealant (Human) Price by Type
6 Fibrin Sealant (Human) Market by Application
- 6.1 Global Fibrin Sealant (Human) Revenue by Application
- 6.1.1 Global Fibrin Sealant (Human) Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Fibrin Sealant (Human) Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Fibrin Sealant (Human) Revenue Market Share by Application (2021-2032)
- 6.2 Global Fibrin Sealant (Human) Sales by Application
- 6.2.1 Global Fibrin Sealant (Human) Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Fibrin Sealant (Human) Sales by Application (2021-2032) & (K Tons)
- 6.2.3 Global Fibrin Sealant (Human) Sales Market Share by Application (2021-2032)
- 6.3 Global Fibrin Sealant (Human) Price by Application
7 Company Profiles
- 7.1 Behringwerke
- 7.1.1 Behringwerke Company Information
- 7.1.2 Behringwerke Business Overview
- 7.1.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Behringwerke Fibrin Sealant (Human) Product Portfolio
- 7.1.5 Behringwerke Recent Developments
- 7.2 CSL
- 7.2.1 CSL Company Information
- 7.2.2 CSL Business Overview
- 7.2.3 CSL Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 CSL Fibrin Sealant (Human) Product Portfolio
- 7.2.5 CSL Recent Developments
- 7.3 Grifols
- 7.3.1 Grifols Company Information
- 7.3.2 Grifols Business Overview
- 7.3.3 Grifols Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Grifols Fibrin Sealant (Human) Product Portfolio
- 7.3.5 Grifols Recent Developments
- 7.4 Immuno
- 7.4.1 Immuno Company Information
- 7.4.2 Immuno Business Overview
- 7.4.3 Immuno Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Immuno Fibrin Sealant (Human) Product Portfolio
- 7.4.5 Immuno Recent Developments
- 7.5 Octapharma
- 7.5.1 Octapharma Company Information
- 7.5.2 Octapharma Business Overview
- 7.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Octapharma Fibrin Sealant (Human) Product Portfolio
- 7.5.5 Octapharma Recent Developments
- 7.6 Baxter
- 7.6.1 Baxter Company Information
- 7.6.2 Baxter Business Overview
- 7.6.3 Baxter Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Baxter Fibrin Sealant (Human) Product Portfolio
- 7.6.5 Baxter Recent Developments
- 7.7 Bayer
- 7.7.1 Bayer Company Information
- 7.7.2 Bayer Business Overview
- 7.7.3 Bayer Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Bayer Fibrin Sealant (Human) Product Portfolio
- 7.7.5 Bayer Recent Developments
- 7.8 Hualan Biological
- 7.8.1 Hualan Biological Company Information
- 7.8.2 Hualan Biological Business Overview
- 7.8.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Hualan Biological Fibrin Sealant (Human) Product Portfolio
- 7.8.5 Hualan Biological Recent Developments
- 7.9 Shanghai RAAS
- 7.9.1 Shanghai RAAS Company Information
- 7.9.2 Shanghai RAAS Business Overview
- 7.9.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Shanghai RAAS Fibrin Sealant (Human) Product Portfolio
- 7.9.5 Shanghai RAAS Recent Developments
8 North America
- 8.1 North America Fibrin Sealant (Human) Market Size by Type
- 8.1.1 North America Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 8.1.2 North America Fibrin Sealant (Human) Sales by Type (2021-2032)
- 8.1.3 North America Fibrin Sealant (Human) Price by Type (2021-2032)
- 8.2 North America Fibrin Sealant (Human) Market Size by Application
- 8.2.1 North America Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 8.2.2 North America Fibrin Sealant (Human) Sales by Application (2021-2032)
- 8.2.3 North America Fibrin Sealant (Human) Price by Application (2021-2032)
- 8.3 North America Fibrin Sealant (Human) Market Size by Country
- 8.3.1 North America Fibrin Sealant (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Fibrin Sealant (Human) Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Fibrin Sealant (Human) Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Fibrin Sealant (Human) Market Size by Type
- 9.1.1 Europe Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 9.1.2 Europe Fibrin Sealant (Human) Sales by Type (2021-2032)
- 9.1.3 Europe Fibrin Sealant (Human) Price by Type (2021-2032)
- 9.2 Europe Fibrin Sealant (Human) Market Size by Application
- 9.2.1 Europe Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 9.2.2 Europe Fibrin Sealant (Human) Sales by Application (2021-2032)
- 9.2.3 Europe Fibrin Sealant (Human) Price by Application (2021-2032)
- 9.3 Europe Fibrin Sealant (Human) Market Size by Country
- 9.3.1 Europe Fibrin Sealant (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Fibrin Sealant (Human) Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Fibrin Sealant (Human) Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Fibrin Sealant (Human) Market Size by Type
- 10.1.1 China Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 10.1.2 China Fibrin Sealant (Human) Sales by Type (2021-2032)
- 10.1.3 China Fibrin Sealant (Human) Price by Type (2021-2032)
- 10.2 China Fibrin Sealant (Human) Market Size by Application
- 10.2.1 China Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 10.2.2 China Fibrin Sealant (Human) Sales by Application (2021-2032)
- 10.2.3 China Fibrin Sealant (Human) Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Fibrin Sealant (Human) Market Size by Type
- 11.1.1 Asia Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 11.1.2 Asia Fibrin Sealant (Human) Sales by Type (2021-2032)
- 11.1.3 Asia Fibrin Sealant (Human) Price by Type (2021-2032)
- 11.2 Asia Fibrin Sealant (Human) Market Size by Application
- 11.2.1 Asia Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 11.2.2 Asia Fibrin Sealant (Human) Sales by Application (2021-2032)
- 11.2.3 Asia Fibrin Sealant (Human) Price by Application (2021-2032)
- 11.3 Asia Fibrin Sealant (Human) Market Size by Country
- 11.3.1 Asia Fibrin Sealant (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Fibrin Sealant (Human) Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Fibrin Sealant (Human) Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Fibrin Sealant (Human) Market Size by Type
- 12.1.1 SAMEA Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 12.1.2 SAMEA Fibrin Sealant (Human) Sales by Type (2021-2032)
- 12.1.3 SAMEA Fibrin Sealant (Human) Price by Type (2021-2032)
- 12.2 SAMEA Fibrin Sealant (Human) Market Size by Application
- 12.2.1 SAMEA Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 12.2.2 SAMEA Fibrin Sealant (Human) Sales by Application (2021-2032)
- 12.2.3 SAMEA Fibrin Sealant (Human) Price by Application (2021-2032)
- 12.3 SAMEA Fibrin Sealant (Human) Market Size by Country
- 12.3.1 SAMEA Fibrin Sealant (Human) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Fibrin Sealant (Human) Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Fibrin Sealant (Human) Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Fibrin Sealant (Human) Value Chain Analysis
- 13.1.1 Fibrin Sealant (Human) Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Fibrin Sealant (Human) Production Mode & Process
- 13.2 Fibrin Sealant (Human) Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Fibrin Sealant (Human) Distributors
- 13.2.3 Fibrin Sealant (Human) Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst